Pediatric Inflammatory Multisystem Syndrome and Rheumatic Diseases During SARS-CoV-2 Pandemic
Globally, the coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), appeared to have a milder clinical course in children compared to adults. As severe forms of COVID-19 in adults included an aberrant systemic immune response, children with chro...
Saved in:
Main Authors: | Adrien Schvartz (Author), Alexandre Belot (Author), Isabelle Kone-Paut (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pediatric Inflammatory Multisystem Syndrome Temporally Related With SARS-CoV-2: Immunological Similarities With Acute Rheumatic Fever and Toxic Shock Syndrome
by: Danilo Buonsenso, et al.
Published: (2020) -
Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 Treated with Tocilizumab
by: Carmen Niño-Taravilla, et al.
Published: (2020) -
Multisystem inflammatory syndrome in children during the COVID-19 waves: data from the Juvenile Inflammatory Rheumatism cohort
by: Robin Kechiche, et al.
Published: (2023) -
SARS-CoV-2-associated multisystem inflammatory syndrome in a child
by: N.M. Nagovitsyna
Published: (2021) -
SARS-CoV-2-related multisystem inflammatory syndrome in children and adolescents
by: Arpita Gupta
Published: (2022)